SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148359
Filing Date
2017-04-28
Accepted
2017-04-28 16:32:08
Documents
6
Period of Report
2017-05-31
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d385091ddef14a.htm DEF 14A 354199
2 GRAPHIC g385091g18s37.jpg GRAPHIC 29379
3 GRAPHIC g385091pcpg01a.jpg GRAPHIC 28482
4 GRAPHIC g385091pcpg01d.jpg GRAPHIC 21674
5 GRAPHIC g385091pcpg01e.jpg GRAPHIC 14071
6 GRAPHIC g385091pcpg02.jpg GRAPHIC 9932
  Complete submission text file 0001193125-17-148359.txt   498143
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36570 | Film No.: 17796115
SIC: 2834 Pharmaceutical Preparations